In 1998, the ACR Research and Education Foundation (REF) funded a total of $500,000 in grants. This year, the REF funded more than $4.6 million in grants through its core portfolio, which is an increase of over $4 million in funding capabilities in just 10 years. The REF also achieved the distinction of becoming the second largest funding source—just behind the National Institutes of Health (NIH)—of rheumatology research and training programs in the United States and was recently awarded the prestigious four-star rating from Charity Navigator. These achievements could not have been realized without the generous financial support of REF donors.
Philadelphia Displays Many Facets of the Healthcare Debate
City of Brotherly Love displays many facets of the healthcare debate
Reading Rheum
Handpicked Reviews of Contemporary Literature
Building on Accomplishments
As I assume the presidency of the REF, I reflect on the accomplishments of the organization over the past two years, and I wish to thank my immediate predecessor, Leslie J. Crofford, MD, for her tremendous leadership. The achievements of the REF during her term have been truly impressive.
A Preceptorship Comes Full Circle
Ephraim P. Engleman, MD, has spent his career drawing attention to the field of rheumatology. Widely regarded as one of the founders of the modern practice of rheumatology, this 98-year-old director of the Rosalind Russell Medical Research Center for Arthritis at the University of California, San Francisco (UCSF), is still working hard at promoting the field.
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
Chance Discovery May Provide RA Diagnostic
Science From Arthritis & Rheumatism
Members, Submitters Share Thoughts on ACR Journals
In an online survey conducted in the spring of 2009, the ACR collected information on journal readership patterns, satisfaction, and content interests. The survey was sent to a sample of ACR and ARHP members who had not submitted manuscripts to Arthritis & Rheumatism (A&R) or Arthritis Care & Research (AC&R) within a recent 12-month period. It was also sent, with additional questions regarding submission and review, to all members and nonmembers who had submitted at least one manuscript to either journal during the 12-month period. Because of the international scope and reputation of the ACR journals, along with the fact that most members are in clinical practice and do not generally conduct and publish research, 63% of the submitters to the journals are not members of the ACR or ARHP. The ACR journals have long been viewed as the place where both members and nonmembers seek to publish their high-quality work.
Within Our Reach–Funded Research May Hold Key to Unlocking the CNS and Suppressing RA
Studies recently published in Arthritis & Rheumatism show that a key chemical produced by the central nervous system (CNS) decreases inflammation and suppresses production of proteins known to play a role in rheumatoid arthritis (RA). This opens the way for developing a novel class of drugs that mimic this effect of the CNS on RA.
Another Vocabulary for Rheumatology Research
Matt Liang, MD, MPH, addresses patients’ authentic concerns
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 123
- Next Page »